Developer docs
API playgroundTry for free, no card

Search company profiles

Validant

Full company profile

uuid0009gx8

Namestring
Validant
Legal namestring
Kinsale Holdings, Inc. dba Validant
Websiteurl
validant.com
Company typeenum
Private
Founded yearint
2005
Descriptiontext

Validant (legally Kinsale Holdings, Inc. dba Validant, Delaware corporation) is a global regulatory, compliance, and quality consulting firm serving the life sciences industry. Founded in 2005 and headquartered in San Francisco, the company provides strategy, execution, and ongoing support services across the full GxP product lifecycle, including preclinical, clinical, manufacturing, and distribution phases. Its client base spans pharmaceutical, biologics, medical device, diagnostics/IVD, and gene and cell therapy manufacturers, including 25 of the top 30 global medical device firms, 20 of the top 30 global pharma firms, and 7 of the top 10 biotech firms. Services are organized by need (Strategic Consulting, Execution Services, Ongoing Support), by phase (Preclinical, Clinical, Manufacturing, Distribution), and by focus area (Regulatory, Compliance, Quality), with specialized offerings in EU MDR/IVDR compliance and ATMP/gene therapy regulatory pathways.

Validant's core differentiator is its consultant bench, composed of former FDA officials, former regulators from global health agencies, and former industry executives from major pharmaceutical and medical device companies (Boston Scientific, Cardinal Healthcare, Sanofi-Aventis, Novartis, SmithKline Beecham). This talent base provides deep expertise in agency navigation, complex regulatory pathways, and remediation work following warning letters, 483 observations, and consent decrees. Delivery is enabled through a curated global consultant network spanning nearly every major country, allowing rapid team scaling from 1 to 100+ consultants within one week. The company operates five regional hubs (San Francisco, Durham, Boston, Cork, Shanghai) and is GDPR-compliant.

Since December 2018, Validant has been owned by GHO Capital Partners, a European specialist healthcare private equity firm, which has executed an aggressive buy-and-build strategy, acquiring DataRevive (2019), IDEC (2020), Oriel STAT A MATRIX (2021), Greenleaf Health (2021), and RApport Global Strategic Services (2024). These acquired firms, along with Validant, were unified in January 2024 under the single ELIQUENT Life Sciences brand. Revenue is generated through professional services engagements on a quote-based, project and retainer model, with multi-year contracts typical. The company does not operate a software platform or AI-native technology layer; value is delivered through human expertise.

Short descriptiontext

Validant is a global regulatory, compliance, and quality consulting firm serving pharmaceutical, biologics, medical device, diagnostics, and gene/cell therapy companies across the full GxP product lifecycle, owned by GHO Capital and operating under the ELIQUENT Life Sciences brand since 2024.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
regulatory affairs consulting, pharmaceutical compliance consulting, medical device regulatory, GxP quality consulting, biologics regulatory services
Industry5 codes
PRIMARYHLAGAKAA
Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAGAKAJ
Manufacturing Quality Assurance & GMP Compliance (batch release, deviation/CAPA, tech transfer QA)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAGAKAI
Clinical Quality Assurance (GCP QA, TMF/QMS oversight)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAGAKAM
Training & Competency Programs for GxP Compliance
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAGAKAG
Computer System Validation (CSV) & GxP IT Compliance (21 CFR Part 11/Annex 11)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
Product category
Regulatory Affairs Consulting
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Regulatory Consulting Services
TypeProfessional Services
Description

Professional consulting services spanning the full GxP product lifecycle including preclinical, clinical, manufacturing, and distribution phases. Revenue is generated through project-based engagements and retainer arrangements for ongoing support.

validant.com
2Compliance Consulting
TypeProfessional Services
Description

Services focused on health authority response, remediation support for consent decrees, warning letters, and 483s. Includes inspection readiness and mock inspections.

validant.com
3Quality Consulting
TypeProfessional Services
Description

Quality management systems design, implementation, and optimization services including QMS strategy, validation, qualification, and ongoing quality operations support.

validant.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Pricing details1 tier
1Consulting engagement - custom pricing based on project scope
ModelOtherBilling cadenceMulti-year contract
Notes

Validant offers complimentary initial consult sessions with partners. Professional services pricing is quote-based and varies by project complexity, duration, and team composition required.

validant.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1ELIQUENT Life Sciences
Description

The unified brand under which the Validant Group of companies operates, combining Validant, Greenleaf Health, DataRevive, Oriel STAT A MATRIX, IDEC, and RApport.

validant.com
Core offering1 text field

Validant provides regulatory, compliance, and quality consulting services to pharmaceutical, biologics, medical device, and diagnostics companies across the full GxP product lifecycle. Services span preclinical, clinical, manufacturing (GMP), and distribution (GDP) phases, delivered through strategic advisory, execution/implementation teams, and ongoing support engagements staffed by former regulators and industry experts.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • 100% passing of 32 IND applications over one year for DataRevive client
Product overview1 text field

Validant (now operating under ELIQUENT Life Sciences) is a full-service global regulatory, compliance, and quality consulting firm providing strategy, execution, and ongoing support services spanning the entire GxP product lifecycle. The core offerings include Strategic Consulting (regulatory strategy, QMS design, data integrity), Execution Services (talent deployment for implementation), and Ongoing Support (monitoring, training, inspection readiness). Services are organized by phase (Preclinical, Clinical, Manufacturing, Distribution) and focus area (Regulatory, Compliance, Quality). The company serves pharmaceuticals, biologics, medical devices, diagnostics, and gene/cell therapies. Validant has expanded through acquisitions including DataRevive (regulatory strategy), Greenleaf Health (FDA consulting), Oriel STAT A MATRIX (medical device training), IDEC (Japan regulatory), and RApport (European regulatory), all operating under the ELIQUENT Life Sciences umbrella alongside a global consultant network.

Product and service22 records
1Strategic Consulting
CategoryCore Service
2Execution Services
CategoryCore Service
3Ongoing Support
CategoryCore Service
4Preclinical Consulting
CategoryPhase-Specific Service
5Clinical Consulting
CategoryPhase-Specific Service
6Manufacturing GMP Consulting
CategoryPhase-Specific Service
7Distribution GDP Consulting
CategoryPhase-Specific Service
8Regulatory Consulting
CategoryFocus Area Service
9Compliance Consulting
CategoryFocus Area Service
10Quality Consulting
CategoryFocus Area Service
11Pharmaceuticals Consulting
CategoryIndustry Vertical
12Biologics Consulting
CategoryIndustry Vertical
13Medical Device Consulting
CategoryIndustry Vertical
14Diagnostics & IVDs Consulting
CategoryIndustry Vertical
15Gene & Cell Therapies Consulting
CategoryIndustry Vertical
16EU MDR/IVDR Compliance Services
CategorySpecialized Service
17COVID-19 Response Services
CategorySpecialized Service
18DataRevive
CategoryAcquired Brand
Description

Partner company specializing in regulatory affairs for small molecule and biological products, featuring former FDA CMC and clinical professionals with expertise in expedited pathways.

19Greenleaf Health
CategoryAcquired Brand
Description

FDA regulatory consulting firm with team of experts drawing on over 300 years of combined FDA experience, providing strategic guidance to pharmaceutical, biotech, and medical device companies.

20Oriel STAT A MATRIX
CategoryAcquired Brand
Description

Global consultancy and training firm for the medical device industry, providing regulatory, quality and compliance consulting along with auditor training, with relationships with 90% of top 10 medical device companies.

21IDEC
CategoryAcquired Brand
Description

Leading regulatory consultancy based in Japan, expanding Validant's geographic reach and providing comprehensive Asian regulatory services.

22RApport Global Strategic Services
CategoryAcquired Brand
Description

UK-based international regulatory consultancy supporting life science innovators in gaining and maintaining product authorization worldwide, with European regulatory expertise.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeOthersAnnounced on2024-01-23
Description

UK-based international regulatory consultancy supporting life science innovators gaining and maintaining authorization for products worldwide. Acquisition expands ELIQUENT's European capabilities and geographic reach.

Strategic tierCoreTypeOthersAnnounced on2021-04-23
Description

Leading FDA regulatory consulting firm acquired by Validant. Greenleaf provides strategic and technical guidance to pharmaceutical, biotechnology, and medical device companies. Team includes former FDA professionals with over 300 years of combined FDA experience. Headquartered in Washington, D.C.

Strategic tierCoreTypeOthersAnnounced on2021-04-15
Description

Global consultancy and training firm for the medical device industry. Headquartered in New Jersey, Oriel provides regulatory, quality and compliance consulting as well as training. Industry leader with relationships with 90% of top 10 medical device companies globally.

Strategic tierCoreTypeOthersAnnounced on2020-11-24
Description

Leading regulatory consultancy based in Japan. Acquired by Validant to expand geographic reach and establish comprehensive Asian regulatory services.

5DataRevive
Strategic tierCoreTypeOthersAnnounced on2019-11-01
Description

Regulatory strategy and consulting business focused on novel therapeutics and biologics. DataRevive's team includes former FDA CMC and clinical professionals providing expertise in expedited pathways including Fast Track, Breakthrough Therapy, and Orphan Drug Designation.

validant.com
Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global clinical and life sciences services giant offering regulatory and quality consulting alongside its core CRO operations. Comparable to Validant as a large-scale GxP advisory provider, though IQVIA operates across a much broader services portfolio including clinical, commercial, and technology offerings.

TypeDirect peer
Description

Specialized regulatory, compliance, and pharmacovigilance consulting firm serving pharmaceutical, biotech, and medical device companies. Closely comparable to Validant in service mix and target customers, though smaller in scale and without Validant's PE-backed acquisition roll-up.

TypeDirect peer
Description

Regulatory affairs, pharmacovigilance, and quality consulting firm serving life sciences companies globally. Highly comparable to Validant's ELIQUENT offering across GxP, with similar geographic footprint and customer segments; recently acquired by Cencora.

TypeBroad incumbent
Description

Global CRO with dedicated regulatory and consulting services across pharma and biotech. Comparable to Validant for enterprise-scale regulatory engagements, though ICON's primary business is clinical trial execution rather than specialized regulatory consulting.

TypeBroad incumbent
Description

Global CRO offering regulatory consulting, clinical development, and post-market services to biopharma clients. Comparable to Validant in regulatory and quality advisory scope, but at much larger scale and with broader clinical services.

TypeBroad incumbent
Description

Clinical and commercial services organization with regulatory and pharmacovigilance capabilities. Comparable to Validant for GxP advisory work, particularly for pharma and biotech customers, though Syneos is much larger and clinical-trail focused.

TypeEmerging player
Description

Regulatory affairs and pharmacovigilance consultancy serving pharma and biotech across Europe, the US, and Asia. Comparable to Validant's regulatory strategy and submission support offerings, though smaller and with a narrower geographic footprint.

TypeBroad incumbent
Description

Big-4 advisory firm with a dedicated life sciences regulatory and quality practice serving pharma, biotech, and medical device companies. Comparable to Validant for enterprise GxP consulting engagements, but operating at significantly larger scale with broader advisory services.

TypeBroad incumbent
Description

Life sciences research and manufacturing services provider with regulatory and quality consulting adjacencies. Comparable to Validant in serving pharma/biotech regulatory needs, though Charles River's core focus is preclinical and manufacturing rather than regulatory consulting.

TypeEmerging player
Description

Specialized regulatory and quality consulting firm serving biopharma, with particular focus on biologics and ATMPs. Comparable to Validant/ELIQUENT in service mix and target customer profile, though operating at a smaller scale.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles14 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries5 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Validant

Regulatory Affairs Consultingvalidant.com

Validant is a global regulatory, compliance, and quality consulting firm serving pharmaceutical, biologics, medical device, diagnostics, and gene/cell therapy companies across the full GxP product lifecycle, owned by GHO Capital and operating under the ELIQUENT Life Sciences brand since 2024.

What Validant does

Validant (legally Kinsale Holdings, Inc. dba Validant, Delaware corporation) is a global regulatory, compliance, and quality consulting firm serving the life sciences industry. Founded in 2005 and headquartered in San Francisco, the company provides strategy, execution, and ongoing support services across the full GxP product lifecycle, including preclinical, clinical, manufacturing, and distribution phases. Its client base spans pharmaceutical, biologics, medical device, diagnostics/IVD, and gene and cell therapy manufacturers, including 25 of the top 30 global medical device firms, 20 of the top 30 global pharma firms, and 7 of the top 10 biotech firms. Services are organized by need (Strategic Consulting, Execution Services, Ongoing Support), by phase (Preclinical, Clinical, Manufacturing, Distribution), and by focus area (Regulatory, Compliance, Quality), with specialized offerings in EU MDR/IVDR compliance and ATMP/gene therapy regulatory pathways.

Validant's core differentiator is its consultant bench, composed of former FDA officials, former regulators from global health agencies, and former industry executives from major pharmaceutical and medical device companies (Boston Scientific, Cardinal Healthcare, Sanofi-Aventis, Novartis, SmithKline Beecham). This talent base provides deep expertise in agency navigation, complex regulatory pathways, and remediation work following warning letters, 483 observations, and consent decrees. Delivery is enabled through a curated global consultant network spanning nearly every major country, allowing rapid team scaling from 1 to 100+ consultants within one week. The company operates five regional hubs (San Francisco, Durham, Boston, Cork, Shanghai) and is GDPR-compliant.

Since December 2018, Validant has been owned by GHO Capital Partners, a European specialist healthcare private equity firm, which has executed an aggressive buy-and-build strategy, acquiring DataRevive (2019), IDEC (2020), Oriel STAT A MATRIX (2021), Greenleaf Health (2021), and RApport Global Strategic Services (2024). These acquired firms, along with Validant, were unified in January 2024 under the single ELIQUENT Life Sciences brand. Revenue is generated through professional services engagements on a quote-based, project and retainer model, with multi-year contracts typical. The company does not operate a software platform or AI-native technology layer; value is delivered through human expertise.

Validant firmographics

Firmographics
Name
Validant
Legal name
Kinsale Holdings, Inc. dba Validant
Website
https://validant.com
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
101–250 employees
Short description
Validant is a global regulatory, compliance, and quality consulting firm serving pharmaceutical, biologics, medical device, diagnostics, and gene/cell therapy companies across the full GxP product lifecycle, owned by GHO Capital and operating under the ELIQUENT Life Sciences brand since 2024.
Ownership category
akta.pro rank

Validant industry classification

Industry
Product category
Regulatory Affairs Consulting
akta.pro industry
PRIMARYHLAGAKAA
Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAGAKAJ
Manufacturing Quality Assurance & GMP Compliance (batch release, deviation/CAPA, tech transfer QA)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAGAKAI
Clinical Quality Assurance (GCP QA, TMF/QMS oversight)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAGAKAM
Training & Competency Programs for GxP Compliance
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAGAKAG
Computer System Validation (CSV) & GxP IT Compliance (21 CFR Part 11/Annex 11)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)

Keywords

  • Regulatory affairs consulting
  • Pharmaceutical compliance consulting
  • Medical device regulatory
  • GxP quality consulting
  • Biologics regulatory services

Where Validant is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Offices5 records

Markets served

Validant business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Regulatory Consulting Services: Professional consulting services spanning the full GxP product lifecycle including preclinical, clinical, manufacturing, and distribution phases. Revenue is generated through project-based engagements and retainer arrangements for ongoing support.
  2. Compliance Consulting: Services focused on health authority response, remediation support for consent decrees, warning letters, and 483s. Includes inspection readiness and mock inspections.
  3. Quality Consulting: Quality management systems design, implementation, and optimization services including QMS strategy, validation, qualification, and ongoing quality operations support.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractConsulting engagement - custom pricing based on project scope

Go-to-market motion2 records

Distribution channels1 record

Marketing channels6 records

Validant product offering

Product offering

Core offering

Validant provides regulatory, compliance, and quality consulting services to pharmaceutical, biologics, medical device, and diagnostics companies across the full GxP product lifecycle. Services span preclinical, clinical, manufacturing (GMP), and distribution (GDP) phases, delivered through strategic advisory, execution/implementation teams, and ongoing support engagements staffed by former regulators and industry experts.

Product overview

Validant (now operating under ELIQUENT Life Sciences) is a full-service global regulatory, compliance, and quality consulting firm providing strategy, execution, and ongoing support services spanning the entire GxP product lifecycle. The core offerings include Strategic Consulting (regulatory strategy, QMS design, data integrity), Execution Services (talent deployment for implementation), and Ongoing Support (monitoring, training, inspection readiness). Services are organized by phase (Preclinical, Clinical, Manufacturing, Distribution) and focus area (Regulatory, Compliance, Quality). The company serves pharmaceuticals, biologics, medical devices, diagnostics, and gene/cell therapies. Validant has expanded through acquisitions including DataRevive (regulatory strategy), Greenleaf Health (FDA consulting), Oriel STAT A MATRIX (medical device training), IDEC (Japan regulatory), and RApport (European regulatory), all operating under the ELIQUENT Life Sciences umbrella alongside a global consultant network.

Differentiator

Problem solved

Functional benefit

Brands

  • ELIQUENT Life Sciences: The unified brand under which the Validant Group of companies operates, combining Validant, Greenleaf Health, DataRevive, Oriel STAT A MATRIX, IDEC, and RApport.

Products and services

  • Strategic Consulting
  • Execution Services
  • Ongoing Support
  • Preclinical Consulting
  • Clinical Consulting
  • Manufacturing GMP Consulting
  • Distribution GDP Consulting
  • Regulatory Consulting
  • Compliance Consulting
  • Quality Consulting
  • Pharmaceuticals Consulting
  • Biologics Consulting
  • Medical Device Consulting
  • Diagnostics & IVDs Consulting
  • Gene & Cell Therapies Consulting
  • EU MDR/IVDR Compliance Services
  • COVID-19 Response Services
  • DataRevive Partner company specializing in regulatory affairs for small molecule and biological products, featuring former FDA CMC and clinical professionals with expertise in expedited pathways.
  • Greenleaf Health FDA regulatory consulting firm with team of experts drawing on over 300 years of combined FDA experience, providing strategic guidance to pharmaceutical, biotech, and medical device companies.
  • Oriel STAT A MATRIX Global consultancy and training firm for the medical device industry, providing regulatory, quality and compliance consulting along with auditor training, with relationships with 90% of top 10 medical device companies.
  • IDEC Leading regulatory consultancy based in Japan, expanding Validant's geographic reach and providing comprehensive Asian regulatory services.
  • RApport Global Strategic Services UK-based international regulatory consultancy supporting life science innovators in gaining and maintaining product authorization worldwide, with European regulatory expertise.

Quantifiable outcome

  • 100% passing of 32 IND applications over one year for DataRevive client

Companies that use Validant

Customer profile

Named customers3 records

Segments5 records

Ideal customer profiles4 records

Validant technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Validant partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core.

  • RApport Global Strategic ServicescoreOthers · 23 January 2024UK-based international regulatory consultancy supporting life science innovators gaining and maintaining authorization for products worldwide. Acquisition expands ELIQUENT's European capabilities and geographic reach.
  • Greenleaf HealthcoreOthers · 23 April 2021Leading FDA regulatory consulting firm acquired by Validant. Greenleaf provides strategic and technical guidance to pharmaceutical, biotechnology, and medical device companies. Team includes former FDA professionals with over 300 years of combined FDA experience. Headquartered in Washington, D.C.
  • Oriel STAT A MATRIXcoreOthers · 15 April 2021Global consultancy and training firm for the medical device industry. Headquartered in New Jersey, Oriel provides regulatory, quality and compliance consulting as well as training. Industry leader with relationships with 90% of top 10 medical device companies globally.
  • IDECcoreOthers · 24 November 2020Leading regulatory consultancy based in Japan. Acquired by Validant to expand geographic reach and establish comprehensive Asian regulatory services.
  • DataRevivecoreOthers · 1 November 2019Regulatory strategy and consulting business focused on novel therapeutics and biologics. DataRevive's team includes former FDA CMC and clinical professionals providing expertise in expedited pathways including Fast Track, Breakthrough Therapy, and Orphan Drug Designation.

Scale indicators5 records

Recent moves8 records

Expansion highlights5 records

Validant competitors and assessment

Company assessment

Broad incumbents

  • IQVIA: Global clinical and life sciences services giant offering regulatory and quality consulting alongside its core CRO operations. Comparable to Validant as a large-scale GxP advisory provider, though IQVIA operates across a much broader services portfolio including clinical, commercial, and technology offerings.
  • ICON plc: Global CRO with dedicated regulatory and consulting services across pharma and biotech. Comparable to Validant for enterprise-scale regulatory engagements, though ICON's primary business is clinical trial execution rather than specialized regulatory consulting.
  • Parexel International: Global CRO offering regulatory consulting, clinical development, and post-market services to biopharma clients. Comparable to Validant in regulatory and quality advisory scope, but at much larger scale and with broader clinical services.
  • Syneos Health: Clinical and commercial services organization with regulatory and pharmacovigilance capabilities. Comparable to Validant for GxP advisory work, particularly for pharma and biotech customers, though Syneos is much larger and clinical-trail focused.
  • Deloitte (Life Sciences Regulatory practice): Big-4 advisory firm with a dedicated life sciences regulatory and quality practice serving pharma, biotech, and medical device companies. Comparable to Validant for enterprise GxP consulting engagements, but operating at significantly larger scale with broader advisory services.
  • Charles River Laboratories: Life sciences research and manufacturing services provider with regulatory and quality consulting adjacencies. Comparable to Validant in serving pharma/biotech regulatory needs, though Charles River's core focus is preclinical and manufacturing rather than regulatory consulting.

Direct peers

  • ProPharma Group: Specialized regulatory, compliance, and pharmacovigilance consulting firm serving pharmaceutical, biotech, and medical device companies. Closely comparable to Validant in service mix and target customers, though smaller in scale and without Validant's PE-backed acquisition roll-up.
  • PharmaLex (now part of Cencora): Regulatory affairs, pharmacovigilance, and quality consulting firm serving life sciences companies globally. Highly comparable to Validant's ELIQUENT offering across GxP, with similar geographic footprint and customer segments; recently acquired by Cencora.

Emerging players

  • Arriello: Regulatory affairs and pharmacovigilance consultancy serving pharma and biotech across Europe, the US, and Asia. Comparable to Validant's regulatory strategy and submission support offerings, though smaller and with a narrower geographic footprint.
  • Biopharma Excellence: Specialized regulatory and quality consulting firm serving biopharma, with particular focus on biologics and ATMPs. Comparable to Validant/ELIQUENT in service mix and target customer profile, though operating at a smaller scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Validant social profiles

Digital presence

Validant compliance and trust

Trust signal

Compliance1 record

Validant financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Validant leadership team

Management profile

Number of profiles

Profiles14 records

Validant subsidiaries and ownership

Company hierarchy

Subsidiaries5 records

Validant funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Validant M&A and investment

M&A and investment

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Validant

What does Validant do?

Validant provides regulatory, compliance, and quality consulting services to pharmaceutical, biologics, medical device, and diagnostics companies across the full GxP product lifecycle. Services span preclinical, clinical, manufacturing (GMP), and distribution (GDP) phases, delivered through strategic advisory, execution/implementation teams, and ongoing support engagements staffed by former regulators and industry experts.

Is Validant a public or private company?

Validant is a private company. It is classified as private equity controlled and is currently operating.

When was Validant founded?

Validant was founded in 2005. It employs 101 to 250 people.

Where is Validant based?

Validant is headquartered in San Francisco, United States, in the North America region.

How does Validant make money?

Three revenue lines are on record. Regulatory Consulting Services are the primary driver. The others are compliance Consulting and quality Consulting.

Who are Validant's main competitors?

Broad incumbents on record are IQVIA, ICON plc, Parexel International, Syneos Health, Deloitte (Life Sciences Regulatory practice) and Charles River Laboratories. Direct peers are ProPharma Group and PharmaLex (now part of Cencora). Emerging players are Arriello and Biopharma Excellence.

Does Validant have an API?

No public API is recorded for Validant.

What industry is Validant in?

Validant's product category is Regulatory Affairs Consulting. Its primary akta.pro industry code is HLAGAKAA, Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA), with a secondary code of HLAGAKAJ, Manufacturing Quality Assurance & GMP Compliance (batch release, deviation/CAPA, tech transfer QA).

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AETOSWireValidant Group of Companies Unite as ELIQUENT Life SciencesValidant Group announced a strategic repositioning uniting five regulatory consultancies into ELIQUENT Life Sciences. The combined capabilities support pharmaceutical, biotechnology, and medical device companies across regulatory, pharmacovigilance, quality, and training services. The move is backed by GHO Capital, which has invested in the group since 2018.Business Wire BlogValidant Group of Companies Unite as ELIQUENT Life SciencesValidant Group announced a strategic repositioning uniting five regulatory consultancies into ELIQUENT Life Sciences. The alliance includes Validant, Greenleaf Health, DataRevive, Oriel Stat-a-Matrix, and IDEC, with acquisitions spanning 2018-2021. GHO Capital supports the repositioning.Business Wire BlogJoseph Jimenez, Global Quality Leader, Joins Validant GroupJoseph Jimenez joined Validant Group as Partner, bringing nearly 30 years of experience in pharmaceutical and medical device quality leadership. He previously served as Vice President of PGT Quality at Teva Pharmaceuticals, leading the $1.6 billion Procter & Gamble-Teva joint venture. At Validant, he will provide strategic guidance on quality systems and regulatory compliance.Business Wire BlogValidant Group Announces New LeadershipTim Dietlin has joined the Validant Group as CEO, bringing over 25 years of leadership experience. He previously served as Global Managing Partner of the Healthcare and Life Sciences Practice at Heidrick & Struggles for eight years. The Validant Group, a life sciences consulting firm, aims to deliver a full-service platform for regulatory clarity.Business Wire BlogValidant Acquires Greenleaf Health, Leading FDA Regulatory Consulting FirmValidant acquired Greenleaf Health, an FDA regulatory consulting firm, and appointed Patrick Ronan as its new CEO. Greenleaf brings over 300 years of FDA experience, and the acquisition supports Validant's international growth strategy with GHO Capital's backing.Business Wire BlogValidant Acquires IDEC, a Leading Regulatory Consultancy in JapanValidant acquired IDEC, a Japanese regulatory consultancy, to expand its geographic reach and combine regulatory expertise. The deal adds a Tokyo office and, with DataRevive in China, creates a broader Asian regulatory practice. Validant plans to integrate IDEC's expertise into its global offering.PR NewswireValidant Names Brian Burns as CEOValidant, a quality and regulatory services firm serving biotech, pharma and medical device companies, announced the appointment of Brian Burns as Chief Executive Officer, effective January 4, 2018. Burns succeeds Brian Healy, who founded Validant in 2005 and will transition to Chairman of the Board. In his new role, Burns will focus on developing the company's service offerings and expanding its global reach, drawing on his extensive background in medical industry quality and regulatory affairs.PR NewswireValidant Expands Senior Leadership TeamValidant, a quality and regulatory services firm serving the biotechnology, pharmaceutical, and medical device industries, has expanded its senior leadership team by appointing Linda Peters and Brian Burns as Senior Vice Presidents of Client Services. Both appointees bring decades of experience from senior roles at major healthcare companies including Baxter Healthcare, MedImmune/AstraZeneca, Takeda Pharmaceuticals, Haemonetics Corporation, Fresenius Medical Care, and Boston Scientific. The CEO stated these additions will enhance Validant's service offerings domestically and internationally and further the firm's growth strategy.